2021
Arrhythmias in Cardiac Sarcoidosis Bench to Bedside
Rosenfeld LE, Chung MK, Harding CV, Spagnolo P, Grunewald J, Appelbaum J, Sauer WH, Culver DA, Joglar JA, Lin BA, Jellis CL, Dickfeld TM, Kwon DH, Miller EJ, Cremer PC, Bogun F, Kron J, Bock A, Mehta D, Leis P, Siontis KC, Kaufman ES, Crawford T, Zimetbaum P, Zishiri ET, Singh JP, Ellenbogen KA, Chrispin J, Quadri S, Vincent LL, Patton KK, Kalbfleish S, Callahan TD, Murgatroyd F, Judson MA, Birnie D, Okada DR, Maulion C, Bhat P, Bellumkonda L, Blankstein R, Cheng RK, Farr MA, Estep JD. Arrhythmias in Cardiac Sarcoidosis Bench to Bedside. Circulation Arrhythmia And Electrophysiology 2021, 14: e009203. PMID: 33591816, PMCID: PMC8142901, DOI: 10.1161/circep.120.009203.BooksConceptsCardiac sarcoidosisF-fluorodeoxyglucose positron emission tomography scansPositron emission tomography scanCardiac magnetic resonance imagingMultiorgan granulomatous diseaseEmission tomography scanCase-based reviewDisease mechanismsUse of pacemakersMagnetic resonance imagingNew diagnostic testsLife-saving importanceExtracardiac sarcoidosisAssociated arrhythmiasHeart failureVentricular tachyarrhythmiasConduction abnormalitiesOptimal careTreatment optionsGranulomatous diseaseTomography scanEarly diagnosisUncertain causeDiagnostic criteriaResonance imaging
2019
SURVIVAL FOLLOWING IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTATION IN PATIENTS WITH CARDIAC SARCOIDOSIS
Higgins A, Annapureddy A, Wang Y, Minges K, Lampert R, Rosenfeld L, Jacoby D, Curtis J, Miller E, Freeman J. SURVIVAL FOLLOWING IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTATION IN PATIENTS WITH CARDIAC SARCOIDOSIS. Journal Of The American College Of Cardiology 2019, 73: 306. DOI: 10.1016/s0735-1097(19)30914-3.Peer-Reviewed Original ResearchUsing FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis
Sharp MB, Soufer A, Abdelmessih M, Rosenfeld LE, Baldassarre LA, Miller EJ. Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis. Journal Of Nuclear Cardiology 2019, 27: 688-690. PMID: 30737635, DOI: 10.1007/s12350-019-01640-z.Peer-Reviewed Original Research
2015
Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator
Kron J, Sauer W, Mueller G, Schuller J, Bogun F, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA, Crawford T. Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator. Journal Of Interventional Cardiac Electrophysiology 2015, 43: 55-64. PMID: 25676929, DOI: 10.1007/s10840-015-9978-3.Peer-Reviewed Original ResearchConceptsCardiac magnetic resonanceImplantable cardiac defibrillatorPositron emission tomographyAppropriate ICD therapyAnti-tachycardia pacingICD therapyCardiac defibrillatorLeft ventricular ejection fractionAppropriate ICD interventionsSecondary prevention indicationTrue natural historyOutcomes of patientsMulticenter retrospective reviewVentricular ejection fractionEnhanced cardiac CTExtracardiac sarcoidosisICD interventionsCardiac sarcoidosisPrevention indicationConsecutive patientsEjection fractionHeart transplantRetrospective reviewSarcoidosis patientsVentricular arrhythmias